¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"angle closure glaucoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pseudoexfoliation glaucoma
    °ÅÁþºñ´Ã³ì³»Àå
  • pupillary block glaucoma
    µ¿°øÂ÷´Ü³ì³»Àå
  • phacolytic glaucoma
    ¼öÁ¤Ã¼¿ëÇØ³ì³»Àå
  • phacomorphic glaucoma
    ¼öÁ¤Ã¼ÆØ´ë³ì³»Àå
  • steroid-induced glaucoma
    ½ºÅ×·ÎÀ̵å³ì³»Àå
  • simple glaucoma
    ´Ü¼ø³ì³»Àå
  • angle
    1. °¢ 2. ±¸¼®
  • angle ostectomy
    °¢ÁøÅλÀÀýÁ¦(¼ú), °¢ÁøÅÎÀý°ñ(¼ú)
  • angle recess
    ¾Õ¹æ°¢°ñ, Àü¹æ°¢Àú, °¢¿À¸ñ
  • angle recession
    ¾Õ¹æ°¢µÚ¹°¸², Àü¹æ°¢ÈÄÅð
  • angle-rotation flap
    °¢µ¹¸²ÇÇÆÇ
  • anterior chamber angle
    ¾Õ¹æ°¢, Àü¹æ°¢
  • columellolabial angle
    ÄÚ±âµÕÀÔ¼ú°¢
  • conchoscaphal angle
    ¼±¹Ý¹è°¢
  • costal angle
    °¥ºñ»À°¢, ´Á°ñ°¢
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • phacomorphic glaucoma
    ¼öÁ¤Ã¼ÆØ´ë³ì³»Àå
  • pigmentary glaucoma
    »ö¼Ò³ì³»Àå
  • pseudoexfoliation glaucoma
    °ÅÁþºñ´Ã³ì³»Àå
  • pupillary block glaucoma
    µ¿°øÂ÷´Ü³ì³»Àå
  • simple glaucoma
    ´Ü¼ø³ì³»Àå
  • steroid-induced glaucoma
    ½ºÅ×·ÎÀ̵å³ì³»Àå
  • thrombotic glaucoma
    Ç÷Àü³ì³»Àå
  • traumatic glaucoma
    ¿Ü»ó³ì³»Àå
  • angle
    °¢, ±¸¼®
  • angle correction
    °¢±³Á¤
  • angle ostectomy
    °¢ÁøÅλÀÀýÁ¦¼ú, °¢ÁøÅÎÀý°ñ¼ú
  • angle recess
    ¾Õ¹æ°¢°ñ, Àü¹æ°¢Àú, °¢¿À¸ñ
  • angle recession
    ¾Õ¹æ°¢µÚ¹°¸², Àü¹æ°¢ÈÄÅð
  • angle-rotation flap
    °¢µ¹¸²ÇÇÆÇ
  • anterior chamber angle
    ¾Õ¹æ°¢
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • primary glaucoma ³ª g. primarium
    ¿ø¹ß³ì³»Àå(ê«Û¡ÖàÒ®î¡)
  • prodromal glaucoma
    Àü±¸(±â)³ì³»Àå
  • pupillary block glaucoma
    µ¿°øÂ÷´Ü³ì³»Àå
  • radiation glaucoma
    ¹æ»ç¼±³ì³»Àå
  • AB plane angle
    ABÆò¸é°¢.
  • Campers angle
    įÆÛ°¢.
  • Cobbs angle
    Äں갢
  • RF flip angle
    °íÁÖÆÄ ¼÷ÀÓ°¢
  • acromial angle
    °ßºÀ °¢(Ì·ÜèÊÇ).
  • acromial angle
    ºÀ¿ì¸®°¢
  • angle of convexity
    »ó¾Çµ¹Ãâµµ(ß¾äÉÔÍõóöô).
  • angle of deviation
    ÆíÀ§°¢(ø¶êÈÊÇ), »ç½Ã°¢.
  • angle of divergence
    ´«¹ú¸²°¢,°³»ê°¢
  • angle of friction
    ¸¶Âû °¢(ؤóÍÊÇ).
  • angle of incidence
    ÀԻ簢.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • complicated glaucoma
    ÇÕº´³ì³»Àå
  • congenital glaucoma
    ¼±Ãµ³ì³»Àå
  • congenital glaucoma
    ¼±Ãµ³ì³»Àå(¡­ÖàÒ®î¡).
  • corticosteroid glaucoma
    ½ºÅ×·ÎÀ̵å³ì³»Àå
  • developmental glaucoma
    ¹ßÀ°ÀÌ»ó³ì³»Àå
  • enzyme glaucoma
    È¿¼Ò³ì³»Àå
  • exfoliation glaucoma
    ºñ´Ã³ì³»Àå, ³«¼³³ì³»Àå
  • ghost cell glaucoma
    ºó¼¼Æ÷³ì³»Àå, À¯·É¼¼Æ÷³ì³»Àå
  • glaucoma
    ³ì³»Àå(ÖàÒ®î¡).
  • glaucoma implant
    ³ì³»ÀåÀåÄ¡, ³ì³»ÀåÀÓÇöõÆ®
  • glaucoma pannus
    ³ì³»ÀåÆÇ´©½º
  • glaucoma provocative test
    ³ì³»ÀåÀ¯¹ß°Ë»ç
  • glaucoma suspect
    ³ì³»ÀåÀÇÁõ
  • hemolytic glaucoma
    ¿ëÇ÷³ì³»Àå
  • hemorrhagic glaucoma
    ÃâÇ÷³ì³»Àå.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PC avoirdupois weight [Lat. pondus civile]; packed cells; paper chromatography; paracortex; parent cell...
CE angle Center-Edge angle
CP angle Cerebello-Pontine angle
CPA Canadian Physiotherapy Association; Canadian Psychiatric Association; carboxypeptidase A; cardiopulm...
IA ibotenic acid; immune adherence; immunoadsorbent; immunobiologic activity; impedance angle; indolami...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
VCS Vascular Closure Staple
LTG Low tension glaucoma
NPG Normal Pressure Glaucoma
NTG Normal tension glaucoma
HTG high tension glaucoma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • angle of friction
    ¸¶Âû °¢
  • angle of incidence
    ÀԻ簢
    ±¤¼±ÀÇ Ãà°ú ´ë»ó¹°ÀÇ Ç¥¸é¿¡ ´ëÇØ ¼ö¼±ÀÌ ÀÌ·ç´Â °¢.
  • angle of mouth
    ±¸°¢
  • angle of reflection
    ¹Ý»ç °¢
    ¹Ý»çµÈ ±¤¼±ÀÇ Ãà°ú ´ë»ó¹°ÀÇ Ç¥¸é¿¡ ´ëÇØ ¼ö¼±ÀÌ ÀÌ·ç´Â °¢.
  • angle of strabismus
    »ç½Ã °¢
  • angle of undercut
    °¢Çü ÷¿Í
  • Angle's classification of malocclusion
    ºÎÁ¤±³ÇÕÀÇ Angle ºÐ·ù
  • Angle's classification of malocclusion Class II
    ºÎÁ¤±³ÇÕÀÇ Angle ºÐ·ù 2±Þ
    ÇÏ¾Ç Á¦ 1´ë±¸Ä¡°¡ »ó¾Ç Á¦ 1´ë±¸Ä¡¿ÍÀÇ °ü°è¿¡¼­ ¿ø½É ȤÀº ÈĹ濡 À§Ä¡ÇÏ´Â ºÎÁ¤±³ÇÕ.
  • Angle's classification of malocclusion division 1
    ºÎÁ¤±³ÇÕÀÇ Angle ºÐ·ù 1·ù
    »óÇÏ¾Ç Á¦ 1´ë±¸Ä¡°¡ ¿ø½É±³ÇÕÀÇ ¾ç»óÀ» º¸À̸鼭 »ó¾Ç ÀüÄ¡ÀÇ °úµµÇÑ ¼øÃø °æ»ç°¡ Ư¡ÀÎ ºÎÁ¤±³ÇÕ.
  • Angle's classification of occlusion
    ±³ÇÕÀÇ Angle ºÐ·ù, ¾Þ±Û¾¾ ºÐ·ù
    1. »óÇÏ¾Ç ±¸Ä¡¿Í ÀýÄ¡ °ü°è¿¡ ±Ù°ÅÇÑ ±³ÇÕÀÇ ºÐ·ù. 2. óÀ½¿¡ ¾Þ±Û¿¡ ÀÇÇØ ±â¼úµÈ ÀüÈÄ¹æ ¾Ç°£ °ü°è¿¡ ´ëÇØ 4°¡Áö ÁÖ¿ä ±¸ºÐÀ¸·Î ¼³¸íµÇ¾ú´ø Á¦ 1´ë±¸Ä¡ÀÇ ±³ÇÕ ¾ç»ó¿¡ ±âÃʸ¦ µÐ ±³Çպзù¹ý.
  • angle`s splint
    ¾Þ±Û ºÎ¸ñ
    ÇÏ¾Ç °ñÀý¿¡ ´ëÇÑ ºÎ¸ñ.
  • anterior chamber angle recession
    Àü¹æ°¢ ÈÄÅð
  • basal angle
    µÎÀú °¢
  • Bennet angle
    Ãø¹æ °ú·Î °æ»ç°¢
    ºñÀÛ¾÷Ãø °úµÎ °æ»ç·Î Áï mandibular lateral translation°ú ½Ã»ó¸é »çÀÌ¿¡ ¼öÆò¸é¿¡¼­ Çü¼ºµÈ °¢µµ.
  • bisecting angle technique
    µî°¢ ÃÔ¿µ¹ý, À̵îºÐ°¢ ÃÔ¿µ¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
ghost cell glaucoma Glaucoma occurring after vitrectomy, arising from erythrocyte membranes blocking outflow channels of aqueous humor.
(05 Mar 2000)
glaucoma <ophthalmology> A group of eye diseases characterised by an increase in intraocular pressure which causes pathological changes in the optic disk and typical defects in the field of vision.
It can be corrected by the use of laser light to punch a hole in the iris to relieve the intraocular pressure within the eye. The procedure is painless and requires no anaesthesia.
(13 Nov 1997)
glaucoma detection You may know of the air puff test or other tests used to measure eye pressure in an eye examination. But, this test alone cannot detect glaucoma. Glaucoma is found most often during an eye examination through dilated pupils after drops are put into the eyes during the exam to enlarge the pupils. This allows the eye care professional to see more of the inside of the eye to check for signs of glaucoma.
(12 Dec 1998)
glaucoma fulminans Acute angle-closure glaucoma rapidly followed by blindness.
(05 Mar 2000)
glaucoma, neovascular A form of secondary glaucoma which develops as a consequence of another ocular disease and is attributed to the forming of new vessels in the angle of the anterior chamber.
(12 Dec 1998)
glaucoma, risk factors If you belong to a high-risk group for glaucoma, have your eyes examined through dilated pupils every 2 years by an eye care professional. High-risk groups include everyone with a family history of glaucoma, everyone over the age of 60 and any Black over the age of 40. (Among Blacks, studies show that glaucoma is: 5 times more likely to occur in Blacks than in Whites and about 4 times more likely to cause blindness in Blacks than in Whites).
(12 Dec 1998)
glaucoma, symptoms at first, there are no symptoms. Vision stays normal, and there is no pain. However, as the disease progress, a person with glaucoma may notice the side vision gradually failing. That is, objects in front may still be seen clearly, but objects to the side may be missed. As the disease worsens, the field of vision narrows and blindness results.
(12 Dec 1998)
glaucoma treatment A laser beam of light is focused on the part of the anterior chamber where the fluid leaves the eye. This results in a series of small changes, which makes it easier for fluid to exit the eye. Over time, the effect of laser surgery may wear off. Patients who have this form of surgery may need to keep taking glaucoma drugs.
Although glaucoma cannot be cured, it can usually be controlled. Medical treatment can be in the form of eyedrops or pills. Some drugs are designed to reduce pressure by slowing the flow of fluid into the eye, while others help to improve fluid drainage. The regular use of medications usually controls the increased fluid pressure. However, these drugs may stop working over time or they may cause side effects so that the eye care professional may select other drugs, change the dose, or use other means to deal with the glaucoma.
Surgery can also help fluid escape from the eye and thereby reduce the pressure. However, surgery is now usually reserved for patients whose pressure cannot be controlled with eyedrops, pills, or laser surgery.
(12 Dec 1998)
phacogenic glaucoma Secondary glaucoma caused by either excessive size or spherical shape of the lens.
Synonym: phacogenic glaucoma.
(05 Mar 2000)
phacolytic glaucoma Glaucoma secondary to hypermature cataract and occlusion of the trabecular drainage meshwork by lens material.
(05 Mar 2000)
phacomorphic glaucoma Secondary glaucoma caused by either excessive size or spherical shape of the lens.
Synonym: phacogenic glaucoma.
(05 Mar 2000)
chronic glaucoma A disorder which is characterised by increased pressure within the eyeball. This occurs secondary to the chronic blockage of normal fluid circulation within the eye. Increased pressure within the eye can cause damage to the optic nerve and eventual blindness. Glaucoma is the leading cause of blindness.
Symptoms include decreased vision, halos around lights (worse at night) and mild chronic headaches. Treatment is generally with beta-blocker eyedrops.
(27 Sep 1997)
pigmentary glaucoma Glaucoma associated with erosion of pigment from the posterior iris, and with an accumulation of pigment particles in the trabecular meshwork.
(05 Mar 2000)
combined glaucoma Glaucoma with angle-closure and open-angle mechanisms in the same eye.
(05 Mar 2000)
compensated glaucoma <ophthalmology> A disorder which is characterised by increased pressure within the eyeball.
This occurs secondary to the chronic blockage of normal fluid circulation within the eye. Increased pressure within the eye can cause damage to the optic nerve and eventual blindness. Glaucoma is the leading cause of blindness.
Symptoms include decreased vision, halos around lights (worse at night) and mild chronic headaches. Treatment is generally with beta-blocker eyedrops.
Synonym: chronic glaucoma, compensated glaucoma, simple glaucoma, glaucoma simplex.
(22 Sep 2002)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á